Barclays’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$237K	Sell	25,437 -145,202	-85%	-$1.26M	﹤0.01%	3589
2025 Q4	$1.28M	Buy	170,639 +76,811	+82%	+$779K	﹤0.01%	3264
2025 Q3	$815K	Sell	93,828 -17,951	-16%	-$107K	﹤0.01%	3493
2025 Q2	$415K	Buy	111,779 +14,737	+15%	+$51.8K	﹤0.01%	3866
2025 Q1	$313K	Sell	97,042 -8,203	-8%	-$38.6K	﹤0.01%	3808
2024 Q4	$586K	Sell	105,245 -9,603	-8%	-$75.4K	﹤0.01%	3728
2024 Q3	$1.24M	Buy	114,848 +67,202	+141%	+$1.12M	﹤0.01%	3213
2024 Q2	$1M	Sell	47,646 -173	-0.4%	-$4.34K	﹤0.01%	2601
2024 Q1	$1.52M	Sell	47,819 -60,890	-56%	-$1.55M	﹤0.01%	2789
2023 Q4	$2.2M	Buy	108,709 +34,774	+47%	+$458K	﹤0.01%	2839
2023 Q3	$941K	Sell	73,935 -68,529	-48%	-$1.15M	﹤0.01%	2375
2023 Q2	$2.57M	Buy	142,464 +85,235	+149%	+$1.57M	﹤0.01%	1718
2023 Q1	$984K	Buy	57,229 +22,556	+65%	+$439K	﹤0.01%	2743
2022 Q4	$770K	Buy	34,673 +23,297	+205%	+$360K	﹤0.01%	3008
2022 Q3	$91K	Buy	11,376 +1,760	+18%	+$15.9K	﹤0.01%	3571
2022 Q2	$68K	Sell	9,616 -2,340	-20%	-$22.7K	﹤0.01%	3924
2022 Q1	$181K	Buy	+11,956	New	+$188K	﹤0.01%	3480